Particle Sciences, Inc.

Formerly known as Particle Sciences, Health – CDMO Division and founded in 1991, Particle Sciences has established itself as a leading contract development and manufacturing organization. Staffed by experienced CDMO industry experts, we offer complex drug product formulation development and manufacturing, drug-eluting device development and manufacturing, and a comprehensive suite of supporting services, including analytical and physical characterization and cGMP clinical supply manufacturing. We specialize in offering a variety of formulation development technologies, including the ability to deal with poorly soluble and highly potent compounds under GxPs in both sterile and non-sterile environments, which helps to distinguish us from other CDMO service providers. We have been providing an array of delivery solutions for poor bioavailability drugs and long-acting injectables & drug-eluting devices since 1991. Today, our Clients include over half of the leading pharmaceutical and biotech companies, foundations, universities, and privately-backed start-ups. Agno Pharmaceuticals is a global small molecule CDMO supplying critical RSMs, intermediates, active pharmaceutical ingredients (APIs), highly potent APIs, sterile APIs, and sterile drug product formulations to large and medium-sized pharmaceutical, biotech, generic and CDMO customers. Founded in 2004, Agno has process development and US-FDA inspected GMP-compliant manufacturing facilities with sterile suspension injectable manufacturing capabilities. In addition, Agno has established a drug product formulation research and development laboratory for complex injectables.